Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLLS | RCKT | LCTX | ||
| Company | Cellectis S.A. ADR | Rocket Pharmaceuticals Inc | Lineage Cell Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 3.15 | 2.85 | 1.2400 | ||
| High | 3.15 | 2.89 | 1.2600 | ||
| Low | 3.15 | 2.80 | 1.2300 | ||
| Latest | 3.16 | 2.80 | 1.2350 | ||
| Change | +0.05 | -0.06 | +0.0050 | ||
| % Change | +1.61% | -2.10% | +0.41% | ||
| Volume | 298 | 365,619 | 338,922 | ||
| 20-Day Average Volume | 49,740 | 2,371,280 | 1,009,478 | ||
| Previous Close | 3.11 | 2.86 | 1.2300 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.32 | 2.88 | 1.2563 | ||
| 20-Day Raw Stochastic | 28.57% | 50.39% | 40.54% | ||
| 20-Day Relative Strength | 41.23 | 41.09 | 43.50 | ||
| Weighted Alpha | +35.39 | -18.59 | +6.24 | ||
| Today's Opinion | 88% Sell | 88% Sell | 100% Sell | ||
| Previous Opinion | 96% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 32% Buy | 24% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.35% since 06/09/26 | +7.55% since 06/09/26 | +2.87% since 06/09/26 | ||
| Low | 3.05 on 06/12/26 | 2.53 on 06/11/26 | 1.2023 on 06/10/26 | ||
| High | 3.41 on 06/10/26 | 2.91 on 06/15/26 | 1.3179 on 06/15/26 | ||
| 1-Month | |||||
| %Chg | -19.64% since 05/15/26 | -12.31% since 05/15/26 | +0.40% since 05/15/26 | ||
| Low | 2.89 on 06/09/26 | 2.53 on 06/11/26 | 1.1800 on 06/09/26 | ||
| High | 3.98 on 05/18/26 | 3.40 on 05/18/26 | 1.3650 on 05/28/26 | ||
| 3-Month | |||||
| %Chg | -10.00% since 03/16/26 | -41.48% since 03/16/26 | -21.56% since 03/16/26 | ||
| Low | 2.89 on 06/09/26 | 2.53 on 06/11/26 | 1.1800 on 06/09/26 | ||
| High | 4.55 on 04/13/26 | 5.14 on 03/26/26 | 1.7500 on 04/17/26 | ||
| 6-Month | |||||
| %Chg | -22.41% since 12/16/25 | -16.91% since 12/16/25 | -30.28% since 12/16/25 | ||
| Low | 2.89 on 06/09/26 | 2.53 on 06/11/26 | 1.1800 on 06/09/26 | ||
| High | 5.10 on 12/29/25 | 5.45 on 03/10/26 | 1.9850 on 03/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 312,054 | 312,295 | 306,637 | ||
| Shares Outstanding, K | 100,339 | 109,194 | 249,298 | ||
| Annual Sales | 79,590,000 | 0 | 14,560,000 | ||
| Annual Net Income | -67,590,000 | -223,120,000 | -63,530,000 | ||
| Last Quarter Sales | 7,550,000 | 0 | 1,730,000 | ||
| Last Quarter Net Income | -17,770,000 | -47,590,000 | -4,810,000 | ||
| 60-Month Beta | 2.86 | 0.48 | 1.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 05/11/26 | -0.42 on 05/07/26 | -0.03 on 05/12/26 | ||
| Earnings Date | 08/03/26 | 08/06/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | N/A | 0.080 on 12/15/03 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||